NIH-funded research NIH-funded research

Understanding how the immune system protects against respiratory viruses.

Official title: Mechanisms of Immune Protection Against Respiratory Viruses

Funded at Washington University · NIH-10824574 · Data updated 2026-11-12

This study is looking at how vaccines help our immune system fight off respiratory viruses and how long that protection lasts, and it's for people who want to understand more about how their bodies respond to vaccines and infections.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 4, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$2,380,350
NIH project number1U19AI181103-01
Project IDNIH-10824574 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation are adults aged 21 and older who are interested in contributing to vaccine research and have not previously been vaccinated against the targeted respiratory viruses.

Less likely to help

Patients who are under 21 years old or those with compromised immune systems may not benefit from this research.

What this research studies

This research investigates the immune responses to respiratory viruses, particularly focusing on how vaccines can generate long-lasting protection. It aims to define the mechanisms that allow the immune system to maintain effective responses after vaccination, including the role of specific immune cells like B cells and T cells. The study will involve human participants to assess how well their immune systems respond to vaccines and infections, providing insights that could lead to improved vaccine designs.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective vaccines that provide long-lasting immunity against respiratory viruses.

How similar studies have gone: Previous research has shown promising results in understanding immune responses to vaccines, indicating that this approach has the potential for significant advancements.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Ellebedy, Ali Hassan — Washington University
  • Study coordinator: Ellebedy, Ali Hassan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.